Thu, May 20, 2021
Wed, May 19, 2021
Tue, May 18, 2021
Mon, May 17, 2021
Fri, May 14, 2021
Thu, May 13, 2021
Wed, May 12, 2021
Tue, May 11, 2021

Tiago Fauth Maintained (ABCL) at Buy with Decreased Target to $51 on, May 14th, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-51-on-may-14th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Tiago Fauth of Credit Suisse, Maintained "AbCellera Biologics Inc." (ABCL) at Buy with Decreased Target from $53 to $51 on, May 14th, 2021.

Tiago has made no other calls on ABCL in the last 4 months.



There are 2 other peers that have a rating on ABCL. Out of the 2 peers that are also analyzing ABCL, 0 agree with Tiago's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Tiago


  • Stephen Willey of "Stifel" Maintained at Strong Buy with Decreased Target to $55 on, Tuesday, March 30th, 2021
  • Puneet Souda of "SVB Leerink" Maintained at Buy with Increased Target to $52 on, Monday, February 8th, 2021

Publication Contributing Sources